StockData
Intuitive Surgical Inc logo

Intuitive Surgical Inc (ISRG) stock

ISRGNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 21, 2026Score 16/3030% above fair value
$420.95−9.58 (-2.23%)

Close on Nov 18, 2026Market cap $145.92BP/E 50.9Yield –

Intuitive Surgical operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Intuitive Surgical's operating income for the twelve months ending Sep 30, 2026 was $3.28B, up 16.6% year over year. For fiscal 2025 it was $2.95B, up 25.4% from the year before. Over ten years it grew 14.8% a year on average. The highest annual figure on record is $2.95B in fiscal 2025.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$2.95B+25.4%
FY2024Dec 31, 2024$2.35B+32.9%
FY2023Dec 31, 2023$1.77B+12.0%
FY2022Dec 31, 2022$1.58B-13.4%
FY2021Dec 31, 2021$1.82B+73.5%
FY2020Dec 31, 2020$1.05B-23.6%
FY2019Dec 31, 2019$1.37B+14.6%
FY2018Dec 31, 2018$1.20B+12.8%
FY2017Dec 31, 2017$1.06B+11.9%
FY2016Dec 31, 2016$949.70M+28.3%
FY2015Dec 31, 2015$740.00M+35.8%
FY2014Dec 31, 2014$544.80M-36.1%
FY2013Dec 31, 2013$852.50M-2.9%
FY2012Dec 31, 2012$878.10M+26.4%
FY2011Dec 31, 2011$694.80M+25.1%
FY2010Dec 31, 2010$555.20M+47.1%
FY2009Dec 31, 2009$377.40M+21.4%
FY2008Dec 31, 2008$310.80M+50.3%
FY2007Dec 31, 2007$206.74M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$592.60M-22.0%
Q2 FY2026Jun 30, 2026$971.90M+30.7%
Q1 FY2026Mar 31, 2026$855.30M+48.0%
Q4 FY2025Dec 31, 2025$864.30M+17.6%
Q3 FY2025Sep 30, 2025$759.70M+31.6%
Q2 FY2025Jun 30, 2025$743.40M+31.0%
Q1 FY2025Mar 31, 2025$578.10M+23.2%
Q4 FY2024Dec 31, 2024$734.90M+63.2%
Q3 FY2024Sep 30, 2024$577.30M+23.9%
Q2 FY2024Jun 30, 2024$567.30M+22.5%
Q1 FY2024Mar 31, 2024$469.40M+21.1%
Q4 FY2023Dec 31, 2023$450.20M+20.9%
Q3 FY2023Sep 30, 2023$465.80M+16.8%
Q2 FY2023Jun 30, 2023$463.20M+16.5%
Q1 FY2023Mar 31, 2023$387.60M-5.0%
Q4 FY2022Dec 31, 2022$372.50M-17.3%
Q3 FY2022Sep 30, 2022$398.90M-9.9%
Q2 FY2022Jun 30, 2022$397.60M-22.2%
Q1 FY2022Mar 31, 2022$408.10M-2.1%
Q4 FY2021Dec 31, 2021$450.40M+8.3%
Q3 FY2021Sep 30, 2021$442.60M+63.7%
Q2 FY2021Jun 30, 2021$511.20M+534.2%
Q1 FY2021Mar 31, 2021$416.80M+47.3%
Q4 FY2020Dec 31, 2020$415.80M+4.6%
Q3 FY2020Sep 30, 2020$270.40M-26.1%
Q2 FY2020Jun 30, 2020$80.60M-77.5%
Q1 FY2020Mar 31, 2020$283.00M+12.2%
Q4 FY2019Dec 31, 2019$397.60M+19.8%
Q3 FY2019Sep 30, 2019$365.70M+16.7%
Q2 FY2019Jun 30, 2019$359.00M+29.4%
Q1 FY2019Mar 31, 2019$252.20M-8.9%
Q4 FY2018Dec 31, 2018$332.00M+0.9%
Q3 FY2018Sep 30, 2018$313.30M+11.7%
Q2 FY2018Jun 30, 2018$277.40M+6.7%
Q1 FY2018Mar 31, 2018$276.70M+43.1%
Q4 FY2017Dec 31, 2017$329.00M+22.4%
Q3 FY2017Sep 30, 2017$280.60M–
Q2 FY2017Jun 30, 2017$259.90M–
Q1 FY2017Mar 31, 2017$193.40M–
Q4 FY2016Dec 31, 2016$268.90M–

More Intuitive Surgical figures

See a number that looks wrong?